Plasma B-type Natriuretic Peptide Level in Patients with Acute Cerebral Infarction According to Infarction Subtype and Infarction Volume

Overview

Journal Int J Med Sci

Specialty General Medicine

Date 2013 Jan 5

PMID 23289011

Citations 10

Authors

Seo Hyun Kim

Ji-Yong Lee

Sang Hyun Park

Hyun-Chan Jang

Eun Ju Lim

Sei-Jin Chang

Sung-Soo Lee

Affiliations

Soon will be listed here.

Abstract

Background: Plasma B-type natriuretic peptide (BNP) is used as a diagnostic marker of cardiovascular diseases. BNP is secreted mainly from the myocardium and has been detected by immunoreactivity in brain and cerebral arteries. The aim of our study was to investigate plasma BNP in patients with acute cerebral infarction according to infarction subtype and infarction volume.

Methods: We studied 141 patients with acute cerebral infarction, classified as large artery atherosclerosis (LAA), cardioembolism (CE), or small vessel disease (SA) according to the Trial of Org 10172 in Acute Stroke Treatment classification. Plasma BNP level was measured in patients and 61 healthy controls. We analyzed various clinical and laboratory variables of patients according to plasma BNP level.

Results: Compared to controls, the patients had higher plasma BNP (11.9 ± 11.7 pg/mL versus 124.6 ± 228.8 pg/mL, p <0.01). The highest quartile BNP group was associated with advanced age, female gender, current non-smoker, atrial fibrillation, heart failure, CE group, increased white blood cell counts, increased high sensitivity C-reactive protein, increased left atrium size, decreased left ventricular ejection fraction, increased initial National Institute of Health Stroke Scale, and increased infarction volume. According to multiple regression analysis, CE group, female gender, and infarction volume were independently associated with plasma BNP. Plasma BNP level showed statistically significant differences among LAA (n = 71), CE (n = 50), and SA (n = 20) groups (p <0.001), and the expression decreased in order of CE (253.8 ± 337.1 pg/mL), LAA (61.6 ± 78.8 pg/mL), and SA (25.3 ± 24.8 pg/mL). Increased plasma BNP correlated with increased infarction volume (r = 0.42, p <0.001).

Conclusions: Plasma BNP may be helpful for prediction of etiologic classification of acute cerebral infarction and infarction volume.

Citing Articles

Neuroinflammation-associated miR-106a-5p serves as a biomarker for the diagnosis and prognosis of acute cerebral infarction.

Du W, Fan L, Du J BMC Neurol. 2023; 23(1):248.

PMID: 37369997 PMC: 10294433. DOI: 10.1186/s12883-023-03241-3.

Elevated NT-proBNP predicts unfavorable outcomes in patients with acute ischemic stroke after thrombolytic therapy.

Zhu Z, Muhammad B, Du B, Gu N, Meng T, Kan S BMC Neurol. 2023; 23(1):203.

PMID: 37221489 PMC: 10204306. DOI: 10.1186/s12883-023-03222-6.

NT-proBNP Levels and Collateral Circulation Status in Patients with Acute Ischemic Stroke.

Shen X, Zhang X, Liu M, Dong N, Liao J, Zhou G Dis Markers. 2023; 2023:5318012.

PMID: 37091896 PMC: 10121344. DOI: 10.1155/2023/5318012.

Changes and significance of serum CXCL-16, GDF-15, PLA-2 levels in patients with cerebral infarction.

Liu X Am J Transl Res. 2021; 13(5):5617-5622.

PMID: 34150166 PMC: 8205804.

Brain-Heart Axis and Biomarkers of Cardiac Damage and Dysfunction after Stroke: A Systematic Review and Meta-Analysis.

Xu C, Zheng A, He T, Cao Z Int J Mol Sci. 2020; 21(7).

PMID: 32231119 PMC: 7178236. DOI: 10.3390/ijms21072347.

References

Daniels L, Maisel A . Natriuretic peptides. J Am Coll Cardiol. 2007; 50(25):2357-68. DOI: 10.1016/j.jacc.2007.09.021. View

Porzionato A, Macchi V, Rucinski M, Malendowicz L, De Caro R . Natriuretic peptides in the regulation of the hypothalamic-pituitary-adrenal axis. Int Rev Cell Mol Biol. 2010; 280:1-39. DOI: 10.1016/S1937-6448(10)80001-2. View

Myers M, Norris J, Hachinski V, Weingert M, Sole M . Cardiac sequelae of acute stroke. Stroke. 1982; 13(6):838-42. DOI: 10.1161/01.str.13.6.838. View

Shi H . Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke. Curr Med Chem. 2009; 16(34):4593-600. PMC: 2819104. DOI: 10.2174/092986709789760779. View

Brosnan M, Clark J, Jeffs B, Negrin C, Van Vooren P, Arribas S . Genes encoding atrial and brain natriuretic peptides as candidates for sensitivity to brain ischemia in stroke-prone hypertensive rats. Hypertension. 1999; 33(1 Pt 2):290-7. DOI: 10.1161/01.hyp.33.1.290. View

Shibazaki K, Kimura K, Okada Y, Iguchi Y, Terasawa Y, Aoki J . Heart failure may be associated with the onset of ischemic stroke with atrial fibrillation: a brain natriuretic peptide study. J Neurol Sci. 2009; 281(1-2):55-7. DOI: 10.1016/j.jns.2009.02.374. View

Adams Jr H, Bendixen B, Kappelle L, Biller J, Love B, Gordon D . Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993; 24(1):35-41. DOI: 10.1161/01.str.24.1.35. View

Levin E, Gardner D, Samson W . Natriuretic peptides. N Engl J Med. 1998; 339(5):321-8. DOI: 10.1056/NEJM199807303390507. View

Okada Y, Shibazaki K, Kimura K, Matsumoto N, Iguchi Y, Aoki J . Brain natriuretic peptide is a marker associated with thrombus in stroke patients with atrial fibrillation. J Neurol Sci. 2010; 301(1-2):86-9. DOI: 10.1016/j.jns.2010.10.017. View

10.

Ashley K, Galla J, Nicholls S . Brain natriuretic peptides as biomarkers for atherosclerosis. Prev Cardiol. 2008; 11(3):172-6. DOI: 10.1111/j.1751-7141.2008.08578.x. View

11.

Di Angelantonio E, De Castro S, Toni D, Sacchetti M, Biraschi F, Prencipe M . Determinants of plasma levels of brain natriuretic peptide after acute ischemic stroke or TIA. J Neurol Sci. 2007; 260(1-2):139-42. DOI: 10.1016/j.jns.2007.04.018. View

12.

Montaner J, Perea-Gainza M, Delgado P, Ribo M, Chacon P, Rosell A . Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke. 2008; 39(8):2280-7. DOI: 10.1161/STROKEAHA.107.505354. View

13.

Jensen J, Atar D, Kristensen S, Mickley H, Januzzi Jr J . Usefulness of natriuretic peptide testing for long-term risk assessment following acute ischemic stroke. Am J Cardiol. 2009; 104(2):287-91. DOI: 10.1016/j.amjcard.2009.03.029. View

14.

Weidemann A, Klanke B, Wagner M, Volk T, Willam C, Wiesener M . Hypoxia, via stabilization of the hypoxia-inducible factor HIF-1alpha, is a direct and sufficient stimulus for brain-type natriuretic peptide induction. Biochem J. 2007; 409(1):233-42. DOI: 10.1042/BJ20070629. View

15.

Casco V, Veinot J, Kuroski de Bold M, Masters R, Stevenson M, de Bold A . Natriuretic peptide system gene expression in human coronary arteries. J Histochem Cytochem. 2002; 50(6):799-809. DOI: 10.1177/002215540205000606. View

16.

Cao L, Yang X . Natriuretic peptides and their receptors in the central nervous system. Prog Neurobiol. 2008; 84(3):234-48. DOI: 10.1016/j.pneurobio.2007.12.003. View

17.

Kimura K, Shibazaki K, Iguchi Y, Aoki J, Sakai K, Sakamoto Y . The combination of elevated BNP and AF as a predictor of no early recanalization after IV-t-PA in acute ischemic stroke. J Neurol Sci. 2009; 290(1-2):37-40. DOI: 10.1016/j.jns.2009.11.014. View

18.

LaPointe M . Molecular regulation of the brain natriuretic peptide gene. Peptides. 2005; 26(6):944-56. DOI: 10.1016/j.peptides.2004.08.028. View

19.

Balion C, Santaguida P, McKelvie R, Hill S, McQueen M, Worster A . Physiological, pathological, pharmacological, biochemical and hematological factors affecting BNP and NT-proBNP. Clin Biochem. 2007; 41(4-5):231-9. DOI: 10.1016/j.clinbiochem.2007.10.005. View

20.

Nakagawa K, Yamaguchi T, Seida M, Yamada S, Imae S, Tanaka Y . Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke. Cerebrovasc Dis. 2005; 19(3):157-64. DOI: 10.1159/000083249. View